Pipeline Territories

Current Product Partners
and Available Partnership Opportunities

Through in-licensing relationships, research collaborations and strategic alliances that complement and extend the Staccato® technology, Alexza is interested in developing partnerships that have the potential to create superior products and improve patients’ lives.

ADASUVE® Commercial Territories

ADASUVE® (AZ-004) – Staccato Loxapine
Ferrer holds commercial rights in Europe, Latin America, Russia, the CIS countries, the Middle East and North Africa countries, Korea, Philippines, and Thailand.

Galen holds commercial rights in the United States.

Lee’s Pharma holds commercial rights in People’s Republic of China.

Available for licensing in all other territories

Partnered Development Programs

AZ-002Staccato alprazolam

Engage Therapeutics holds worldwide development and commercial rights.

Development Programs

This email address is being protected from spambots. You need JavaScript enabled to view it. – Staccato fentanyl for cancer breakthrough pain
AZ-007 – Staccato zaleplon for middle of the night awakening

Available for licensing in all territories

To discuss partnership and licensing opportunities, please contact our Business Development Group.

Corporate Headquarters
2091 Stierlin Court
Mountain View, CA 94043
TEL: 650 944 7000
FAX: 650 944 7999
Email Us
Back to top
Scroll for more